“…The identification of patients at risk of CNS relapse remains inconclusive [23]; however, data from immunocompetent individuals suggest that advanced stage, elevated serum LDH and extranodal disease [87] and involvement of specific anatomical sites such as: testes [88,89], paranasal sinuses [90], paraspinal disease, breast [91], renal [84], epidural space [92] and bone [93,94], predict a higher likelihood of CNS relapse.…”